Recent research in fragile X-associated tremor/ataxia syndrome.
Journal
Current opinion in neurobiology
ISSN: 1873-6882
Titre abrégé: Curr Opin Neurobiol
Pays: England
ID NLM: 9111376
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
07
06
2021
revised:
22
10
2021
accepted:
02
11
2021
pubmed:
11
12
2021
medline:
2
4
2022
entrez:
10
12
2021
Statut:
ppublish
Résumé
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a cytosine-guanine-guanine repeat expansion neurological disease that occurs in a subset of aging carriers of the premutation (55-200 cytosine-guanine-guanine repeats) in the FMR1 gene located on the X chromosome. The clinical core involves intention tremor and gait ataxia. Current research seeks to clarify the pathophysiology and neuropathology of FXTAS, as well as the development of useful biomarkers to track the progression of FXTAS. Efforts to implement quantitative measures of clinical features, such as kinematics and cognitive measures, are of special interest, in addition to characterize the differences in progression in males compared with females and the efficacy of new treatments.
Identifiants
pubmed: 34890957
pii: S0959-4388(21)00133-1
doi: 10.1016/j.conb.2021.11.006
pii:
doi:
Substances chimiques
FMR1 protein, human
0
Fragile X Mental Retardation Protein
139135-51-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-159Subventions
Organisme : NICHD NIH HHS
ID : R01 HD036071
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103526
Pays : United States
Informations de copyright
Copyright © 2021. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Conflict of interest statement Nothing declared.